{"anticipatedPostingDate":"2027-06","denomUnitsSelected":"Participants","description":"The PRO-CTCAE is a patient-reported outcome measure developed to evaluate symptomatic toxicity in participants on cancer clinical trials. The PRO-CTCAE includes an item library of 124 items representing 78 symptomatic toxicities drawn from the CTCAE.","reportingStatus":"NOT_POSTED","timeFrame":"Up to 73 months","title":"Number of Participants With Maximum Post-baseline Change From Baseline in Individual Items of Patient-Reported Outcome Version of the Common Term Criteria for Adverse Events (PRO-CTCAE)","type":"SECONDARY"}